Hovione announces New Pharma Campus expansion in New Jersey
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
This expansion in New Jersey will create up to 100 jobs over the next few years is part of a global expansion strategy
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Investment More Than Doubles Capacity for Spray Drying, a Critical Solubility Enhancement Technology That Could Benefit the Development of 70% of Drugs*
Top health and safety standards recognized
Specialty Chemicals Magazine, May 23, 2017
Silicon Republic, October 2, 2020
C&EN, 17 January 2022
Commitment to partnership and joint innovation for cell and gene therapies
European Pharmaceutical Review, 4 November 2025
Executiva, 23 February 2026